Insulet Corporation
PODDMedical Devices
$149.68−1.85%As of Oct 30vs prior close
- Market cap
- $10.4B
- P/E (TTM)
- 27.9×
- P/E (FY1)
- 23.0×
- From 52W high
- −56.78%
- EPS (LTM)
- $5.33
- Revenue (LTM)
- $3.1B
- Net margin
- 12.29%
- Dividend yield
- 0.00%
Nomior Score
53
Anchored CompounderTop 43% of the scored universe
Growth76
Quality77
Value58
Momentum1
Resilience51
Growth
+24.87%revenue a year over 9 fiscal years
FY16 $367MLTM $3.1B
Connections
Revenue to profitQ2 FY26
12% of revenue became net profit, up 8 pts on a year.
Who owns it
5funds